Managing infection in cancer patients and other immunocompromised children

Ochsner Journal

Volumn 12, Issue 3, 2012, Pages 202-210

  Steele, Russell W ^a,b  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Bacteremia; Cancer; Fever; Immunodeficiency; Infection; Neutropenia

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; AZLOCILLIN; AZTREONAM; BENZATHINE PENICILLIN; CEFEPIME; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; COTRIMOXAZOLE; FLUCONAZOLE; IMMUNOGLOBULIN; INTERFERON; KETOCONAZOLE; MENINGOCOCCUS VACCINE; MEROPENEM; MEZLOCILLIN; PENICILLIN V; PIPERACILLIN PLUS TAZOBACTAM; PNEUMOCOCCUS VACCINE; TICARCILLIN; TIMENTIN; VANCOMYCIN;

ATAXIA TELANGIECTASIA; B LYMPHOCYTE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CANDIDEMIA; CD4+ T LYMPHOCYTE; CHRONIC GRANULOMATOUS DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; COMPLEMENT DEFICIENCY; CUTANEOUS ANERGY; DIGEORGE SYNDROME; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISEASE TRANSMISSION; FEBRILE NEUTROPENIA; FELTY SYNDROME; HIGH RISK PATIENT; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPER IGE SYNDROME; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; INFECTION PREVENTION; MUCOCUTANEOUS CANDIDIASIS; MYCOSIS; NEUTROPENIA; NEUTROPHIL COUNT; PNEUMOCOCCAL INFECTION; PNEUMOCYSTIS PNEUMONIA; PROTOZOAL INFECTION; REVIEW; SEPSIS; SEVERE COMBINED IMMUNODEFICIENCY; STAPHYLOCOCCUS INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSIENT HYPOGAMMAGLOBULINEMIA OF INFANCY; TREATMENT DURATION; TREATMENT INDICATION; VIRUS INFECTION; VIRUS REACTIVATION; WISKOTT ALDRICH SYNDROME; X LINKED AGAMMAGLOBULINEMIA;

EID: 84866489398     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Hübel K, Hegener K, Schnell R, et al. Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia. Ann Hematol. 1999 Feb;78(2):73-77.
2. Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis. 2005 Apr 1;40 Suppl 4:S240-S245.
3. Klastersky J, Paesmans M, Rubenstein EB, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000 Aug;18(16):3038-3051.
4. Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion. 2001 Dec;41(12):1493-1499.
5. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007 Dec 20;357(25):2601-2614.
6. Bonilla FA, Bernstein IL, Khan DA, et al; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005 May;94(5 Suppl 1):S1-S63. Erratum in: Ann Allergy Asthma Immunol. 2006 Mar;96(3):504.
7. Sievers EL, Dale DC. Non-malignant neutropenia. Blood Rev. 1996 Jun;10(2):95-100.
8. Dale DC, Liles WC, Price TH. Renewed interest in granulocyte transfusion therapy. Br J Haematol. 1997 Sep;98(3):497-501.
9. Rolston KV. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia. Clin Infect Dis. 2005 Apr 1;40 Suppl 4:S246-S252.
10. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011 Feb 15;52(4):427-431. Epub 2011 Jan 4.
11. Koh A, Pizzo PA. Empirical oral antibiotic therapy for low risk febrile cancer patients with neutropenia. Cancer Invest. 2002; 20(3):420-433.
12. Klastersky J, Paesmans M, Georgala A, et al. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications. J Clin Oncol. 2006 Sep 1;24(25): 4129-4134.
13. Steele RW, Suttle DE, LeMaster PC, Patterson FD, Canales L. Screening for cell-mediated immunity in children. Am J Dis Child. 1976 Nov;130(11):1218-1221.